11/22/2024
5:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:06 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:08 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:09 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:08 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:53 AM | Madison Avenue Partners, LP (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
|
11/14/2024
5:06 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:42 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
2:33 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Theravance Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/24/2024
3:44 PM | BlackRock, Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
09/23/2024
5:05 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:42 PM | BAUPOST GROUP LLC/MA (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A | |
08/22/2024
7:03 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:05 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:07 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
7:09 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:02 PM | Samaha Eli (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
5:05 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:57 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/12/2024
5:15 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:02 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:04 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:06 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:08 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:10 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
5:26 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
5:01 PM | Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:02 PM | BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:04 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:06 PM | GRAY SUSANNAH (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:09 PM | MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:10 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:12 PM | PAKIANATHAN DEEPIKA (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
3:15 PM | Theravance Biopharma (Filer)
| Form DEF 14A | |
04/04/2024
5:09 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:11 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Most People Are Dead Wrong. (Ad) Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence.
Everyone's talking about AI right now.
But see, I've been talking about it for years. I call it my AI Retirement Playbook. I recommend you check it out now. |
04/04/2024
5:13 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:15 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
5:17 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:06 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:01 AM | Theravance Biopharma (Subject)
Weiss Asset Management LP (Filed by)
| Form SC 13D/A | |
02/22/2024
7:04 PM | Farnum Rhonda (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:06 PM | GRAHAM RICHARD A (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:08 PM | Grimaud Brett A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:10 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:11 PM | Sawaf Aziz (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:14 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:12 PM | Miller Aine (Reporting)
Theravance Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2024
5:16 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
5:07 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
5:01 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
5:06 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/26/2023
5:09 PM | Grant Jeremy T (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:10 PM | Theravance Biopharma (Filer)
| Form DEFA14A | |
12/21/2023
4:06 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
